Veterinary Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2026

Chapter 1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary
3.1. Global Veterinary Drugs Market : Snapshot, 2018
3.2. Global Veterinary Drugs Market : Opportunity Map

Chapter 4. Market Overview
4.1. Product Overview
4.2. Global Veterinary Drugs Market Size (US$ Mn) Forecast, 2014–2026
4.3. Global Veterinary Drugs Market Outlook
4.4. Global Veterinary Drugs Market : Key Industry Events
4.5. Global Veterinary Drugs Market : Porter's Analysis
4.6. Key Product Opportunities

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increase in pet ownership & spending on companion animals
5.2.2. Increased medical and surgical capabilities for companion animals
5.2.3. Greater emphasis on prevention and wellness by veterinarians and owners
5.2.4. Evolution of new products to combat emergence of new diseases particularly to cope with zoonotic disease concerns
5.2.5. Increased meat consumption and demand for high quality proteins driving demand for livestock animals
5.3. Restraints
5.3.1. Lack of novel veterinary drugs in the global market
5.3.2. Rising concern about the use of antibiotics and growth promoters in food animals
5.3.3. Prevalence of counterfeit medicines
5.4. Global Veterinary Drugs Market : Opportunity Analysis
5.5. Opportunities
5.5.1. Biologics and specialty care offer potential opportunities for players
5.5.2. Growing awareness and affordability of drugs for pets and livestock offer significant opportunity to new entrants
5.6. Key Trends
5.6.1. Launch of generic versions of veterinary drugs by prominent players
5.6.2. Increase in pet insurance globally
5.6.3. Targeted in-licensing and strategic acquisitions by leading players
5.6.4. Viral disease outbreak demands newer medicines every time

Chapter 6. Veterinary Drugs Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Veterinary Drugs Market Value Share Analysis, by Product Type
6.4. Veterinary Drugs Market Analysis, by Product Type
6.4.1. Anti-infective
6.4.2. Anti-inflammatory
6.4.3. Parasiticides
6.4.4. Others
6.5. Market Attractiveness Analysis, by Product Type
6.6. Key Trends

Chapter 7. Veterinary Drugs Market Analysis, by Animal Type
7.1. Key Findings
7.2. Introduction
7.3. Global Veterinary Drugs Market Value Share Analysis, by Animal Type
7.4. Veterinary Drugs Market Analysis, by Animal Type
7.4.1. Companion
7.4.2. Livestock
7.5. Market Attractiveness Analysis, by Animal Type
7.6. Key Trends

Chapter 8. Veterinary Drugs Market Analysis, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.3. Global Veterinary Drugs Market Value Share Analysis, by Route of Administration
8.4. Veterinary Drugs Market Analysis, by Route of Administration
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
8.5. Market Attractiveness Analysis, by Route of Administration
8.6. Key Trends

Chapter 9. Veterinary Drugs Market Analysis, by Region
9.1. Global Veterinary Drugs Market Snapshot, by Country
9.2. Global Veterinary Drugs Market Value Share Analysis, by Region
9.3. Veterinary Drugs Market Forecast, by Region
9.4. Market Attractiveness Analysis, by Region

Chapter 10. North America Veterinary Drugs Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. Market Analysis, by Product
10.3.1. Market Value Share Analysis, by Product
10.3.2. Market Size (US$ Mn) Forecast, by Product
10.3.2.1. Anti-infective
10.3.2.2. Anti-inflammatory
10.3.2.3. Parasiticides
10.3.2.4. Others
10.4. Market Analysis, by Animal
10.4.1. Market Value Share Analysis, by Animal
10.4.2. Market Size (US$ Mn) Forecast, by Animal
10.4.2.1. Companion
10.4.2.2. Livestock
10.5. Market Analysis, by Route of Administration
10.5.1. Market Value Share Analysis, by Route of Administration
10.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
10.5.2.1. Oral
10.5.2.2. Parenteral
10.5.2.3. Topical
10.6. Market Analysis, by Country
10.6.1. Market Value Share Analysis, by Country
10.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2026
10.6.2.1. U.S.
10.6.2.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. by Product
10.7.2. by Animal
10.7.3. by Route of Administration
10.7.4. by Country
10.8. Market Trends

Chapter 11. Europe Veterinary Drugs Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Market Analysis, by Product
11.3.1. Market Value Share Analysis, by Product
11.3.2. Market Size (US$ Mn) Forecast, by Product
11.3.2.1. Anti-infective
11.3.2.2. Anti-inflammatory
11.3.2.3. Parasiticides
11.3.2.4. Others
11.4. Market Analysis, by Animal
11.4.1. Market Value Share Analysis, by Animal
11.4.2. Market Size (US$ Mn) Forecast, by Animal
11.4.2.1. Companion
11.4.2.2. Livestock
11.5. Market Analysis, by Route of Administration
11.5.1. Market Value Share Analysis, by Route of Administration
11.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
11.5.2.1. Oral
11.5.2.2. Parenteral
11.5.2.3. Topical
11.6. Market Analysis, by Country
11.6.1. Market Value Share Analysis, by Country
11.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2026
11.6.2.1. U.K.
11.6.2.2. Germany
11.6.2.3. Italy
11.6.2.4. France
11.6.2.5. Spain
11.6.2.6. Russia
11.6.2.7. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. by Product
11.7.2. by Animal
11.7.3. by Route of Administration
11.7.4. by Country
11.8. Market Trends

Chapter 12. Asia Pacific Veterinary Drugs Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Market Analysis, by Product
12.3.1. Market Value Share Analysis, by Product
12.3.2. Market Size (US$ Mn) Forecast, by Product
12.3.2.1. Anti-infective
12.3.2.2. Anti-inflammatory
12.3.2.3. Parasiticides
12.3.2.4. Others
12.4. Market Analysis, by Animal
12.4.1. Market Value Share Analysis, by Animal
12.4.2. Market Size (US$ Mn) Forecast, by Animal
12.4.2.1. Companion
12.4.2.2. Livestock
12.5. Market Analysis, by Route of Administration
12.5.1. Market Value Share Analysis, by Route of Administration
12.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
12.5.2.1. Oral
12.5.2.2. Parenteral
12.5.2.3. Topical
12.6. Market Analysis, by Country
12.6.1. Market Value Share Analysis, by Country
12.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2026
12.6.2.1. China
12.6.2.2. Japan
12.6.2.3. India
12.6.2.4. Australia & New Zealand
12.6.2.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. by Product
12.7.2. by Animal
12.7.3. by Route of Administration
12.7.4. by Country
12.8. Market Trends

Chapter 13. Latin America Veterinary Drugs Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Market Analysis, by Product
13.3.1. Market Value Share Analysis, by Product
13.3.2. Market Size (US$ Mn) Forecast, by Product
13.3.2.1. Anti-infective
13.3.2.2. Anti-inflammatory
13.3.2.3. Parasiticides
13.3.2.4. Others
13.4. Market Analysis, by Animal
13.4.1. Market Value Share Analysis, by Animal
13.4.2. Market Size (US$ Mn) Forecast, by Animal
13.4.2.1. Companion
13.4.2.2. Livestock
13.5. Market Analysis, by Route of Administration
13.5.1. Market Value Share Analysis, by Route of Administration
13.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
13.5.2.1. Oral
13.5.2.2. Parenteral
13.5.2.3. Topical
13.6. Market Analysis, by Country
13.6.1. Market Value Share Analysis, by Country
13.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2026
13.6.2.1. Brazil
13.6.2.2. Mexico
13.6.2.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. by Product
13.7.2. by Animal
13.7.3. by Route of Administration
13.7.4. by Country
13.8. Market Trends

Chapter 14. Middle East & Africa Veterinary Drugs Market Analysis
14.1. Key Findings
14.2. Market Overview
14.3. Market Analysis, by Product
14.3.1. Market Value Share Analysis, by Product
14.3.2. Market Size (US$ Mn) Forecast, by Product
14.3.2.1. Anti-infective
14.3.2.2. Anti-inflammatory
14.3.2.3. Parasiticides
14.3.2.4. Others
14.4. Market Analysis, by Animal
14.4.1. Market Value Share Analysis, by Animal
14.4.2. Market Size (US$ Mn) Forecast, by Animal
14.4.2.1. Companion
14.4.2.2. Livestock
14.5. Market Analysis, by Route of Administration
14.5.1. Market Value Share Analysis, by Route of Administration
14.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
14.5.2.1. Oral
14.5.2.2. Parenteral
14.5.2.3. Topical
14.6. Market Analysis, by Country
14.6.1. Market Value Share Analysis, by Country
14.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2026
14.6.2.1. GCC Countries
14.6.2.2. South Africa
14.6.2.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. by Product
14.7.2. by Animal
14.7.3. by Route of Administration
14.7.4. by Country
14.8. Market Trends

Chapter 15. Company Profiles
15.1. Veterinary Drugs Market Share Analysis, by Company, 2016 (Estimated)
15.2. Competition Matrix
15.3. Company Profiles
15.3.1. Bayer AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Boehringer Ingelheim GmbH
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Ceva Santé Animale
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Dechra Pharmaceuticals PLC
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Eli Lilly and Company (Elanco Animal Health)
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Merck Animal Health
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Virbac
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Vetoquinol S.A.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Zoetis, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview